Insights

Innovative Oncology Focus Byondis specializes in developing targeted cancer therapies, particularly antibody-drug conjugates (ADCs), opening opportunities for partnerships in oncology drug delivery, biomarker identification, and combination treatments with existing cancer therapeutics.

Advanced Technology Platform With proprietary linker-drug technology and the newly launched ByonGuard masking technology, Byondis offers cutting-edge solutions that could appeal to pharmaceutical companies seeking innovative ADC components, technology licensing, or co-development collaborations.

Strategic Partnerships The company's recent collaboration with Medac for drug commercialization illustrates openness to partnership and licensing deals, providing avenues for sales expansion through co-marketing or distribution agreements in European markets.

Robust R&D Infrastructure Operating fully integrated in-house R&D and GMP manufacturing facilities in Nijmegen positions Byondis as a reliable partner for custom contract manufacturing, clinical batch production, and R&D services for new biologics and ADC products.

Growing Lead Portfolio With leading assets like SYD985 in development, Byondis presents opportunities to connect with biotech and pharma companies seeking innovative assets for licensing, investment, or co-development in the fast-growing targeted cancer therapy space.

Byondis Tech Stack

Byondis uses 8 technology products and services including Illumina, Google Fonts API, DocuSign, and more. Explore Byondis's tech stack below.

  • Illumina
    Data Management
  • Google Fonts API
    Font Scripts
  • DocuSign
    Miscellaneous
  • Windows 10
    Operating Systems
  • three.js
    Programming Languages
  • Citrix
    Virtualisation Software
  • Google Analytics
    Web Analytics
  • Apache HTTP Server
    Web Servers

Media & News

Byondis's Email Address Formats

Byondis uses at least 1 format(s):
Byondis Email FormatsExamplePercentage
First.Last@byondis.comJohn.Doe@byondis.com
86%
First.MiddleLast@byondis.comJohn.MichaelDoe@byondis.com
8%
FirstMiddleLast@byondis.comJohnMichaelDoe@byondis.com
4%
FL@byondis.comJD@byondis.com
2%

Frequently Asked Questions

Where is Byondis's headquarters located?

Minus sign iconPlus sign icon
Byondis's main headquarters is located at 4 Microweg Nijmegen, Gelderland 6545 cm Netherlands. The company has employees across 1 continents, including Europe.

What is Byondis's official website and social media links?

Minus sign iconPlus sign icon
Byondis's official website is byondis.com and has social profiles on LinkedIn.

What is Byondis's NAICS code?

Minus sign iconPlus sign icon
Byondis's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Byondis have currently?

Minus sign iconPlus sign icon
As of April 2026, Byondis has approximately 261 employees across 1 continents, including Europe. Key team members include Ceo: C. K.Chief Medical Officer: L. D.Chief Human Resources Officer: A. V. A.. Explore Byondis's employee directory with LeadIQ.

What industry does Byondis belong to?

Minus sign iconPlus sign icon
Byondis operates in the Pharmaceutical Manufacturing industry.

What technology does Byondis use?

Minus sign iconPlus sign icon
Byondis's tech stack includes IlluminaGoogle Fonts APIDocuSignWindows 10three.jsCitrixGoogle AnalyticsApache HTTP Server.

What is Byondis's email format?

Minus sign iconPlus sign icon
Byondis's email format typically follows the pattern of First.Last@byondis.com. Find more Byondis email formats with LeadIQ.

When was Byondis founded?

Minus sign iconPlus sign icon
Byondis was founded in 2012.

Byondis

Pharmaceutical ManufacturingGelderland, Netherlands201-500 Employees

Driven to improve patients’ lives, Byondis is an independent, fully integrated biopharmaceutical research and development company creating innovative targeted medicines for cancer. The company is developing new biological entities (NBEs) with a focus on antibody-drug conjugates.

Byondis’ development portfolio leverages its expertise in linker-drug (LD) technology, antibody-drug conjugation and disease biology. Byondis’ fully integrated drug development capabilities cover all stages from pre-clinical and clinical R&D, production of clinical batches of the selected product candidates and regulatory filings, which are all done in-house.

The company has a dedicated team of more than 200 staff working in its state-of-the-art R&D and GMP manufacturing facilities in Nijmegen, the Netherlands.

Section iconCompany Overview

Headquarters
4 Microweg Nijmegen, Gelderland 6545 cm Netherlands
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2012
Employees
201-500

Section iconFunding & Financials

  • $1M$10M

    Byondis's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Byondis's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.